Variant report
Variant | nsv519199 |
---|---|
Chromosome Location | chr3:159248823-159259124 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140789236 | chr3:159252835-159252836 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576930984 | chr3:159252856-159252857 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541011362 | chr3:159252869-159252870 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34532017 | chr3:159252952-159252953 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184845296 | chr3:159252963-159252964 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529667185 | chr3:159252977-159252978 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114378217 | chr3:159253008-159253009 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562908770 | chr3:159253075-159253076 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144622394 | chr3:159253085-159253086 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573039357 | chr3:159253092-159253093 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552202791 | chr3:159253124-159253125 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571756636 | chr3:159253128-159253129 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs545327230 | chr3:159253144-159253145 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548155393 | chr3:159253148-159253149 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
15 | rs566362482 | chr3:159253237-159253238 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
16 | rs374635480 | chr3:159253262-159253263 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145687002 | chr3:159253277-159253278 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569989586 | chr3:159253392-159253393 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537160069 | chr3:159253403-159253404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368742417 | chr3:159253437-159253438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559003193 | chr3:159253509-159253510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577013885 | chr3:159253533-159253534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189328983 | chr3:159253541-159253542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs148505606 | chr3:159253631-159253632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555882482 | chr3:159253633-159253634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569611505 | chr3:159253660-159253661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574406291 | chr3:159253695-159253696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541691465 | chr3:159253723-159253724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562947492 | chr3:159253758-159253759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530483017 | chr3:159253772-159253773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs202139900 | chr3:159253779-159253780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545620667 | chr3:159253780-159253781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115792364 | chr3:159253840-159253841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181668509 | chr3:159253918-159253919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548026414 | chr3:159253949-159253950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574173098 | chr3:159253970-159253971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566250355 | chr3:159253995-159253996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61794726 | chr3:159254014-159254015 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs112729037 | chr3:159254027-159254028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185896515 | chr3:159254073-159254074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112946057 | chr3:159254100-159254101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs375791196 | chr3:159254175-159254176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142245166 | chr3:159254213-159254214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558815080 | chr3:159254233-159254234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs544641987 | chr3:159254236-159254237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570905736 | chr3:159254304-159254305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs534757048 | chr3:159254350-159254351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79775078 | chr3:159254365-159254366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs727234 | chr3:159254385-159254386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs369168293 | chr3:159254390-159254391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:159252800-159253400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr3:159253400-159256200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr3:159253600-159257000 | Enhancers | Liver | Liver |
4 | chr3:159255800-159256600 | Enhancers | Rectal Smooth Muscle | rectum |
5 | chr3:159258200-159259400 | Enhancers | Fetal Brain Male | brain |